40 phd-computer-architecture-"Meta"-"Meta" Fellowship research jobs at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
, faster, longer? Future of Healthful Work – a large scale interdisciplinary program we’re leading asks the question “what if work were healthful from the outset, rather than being something from which we
-
delivery of our innovative NxtGen Researcher Programme and help establish the NxtGen Researcher Academy. This multi-disciplinary position focuses on engaging young people in health research, combining
-
based at the School of Electronics and Computer Science, Southampton. The project is researching, developing and evaluating decentralised algorithms, meta-information data structures and indexing
-
Audition for Robots (ActivATOR)” under the direction of Dr Christine Evers. The position will be in the Vision, Learning and Control (VLC) Group, which is part of the School of Electronics and Computer
-
, along with an aptitude for developing new experimental techniques that relate to this exciting research program. To be successful with your application, you will need to demonstrate: An awarded PhD in
-
The University of Southampton are seeking to appoint a fixed term research fellow to facilitate and deliver a programme of research on a Faraday Institution funded project: SL2FBat - Sustainable Low
-
Computer Science, Southampton. The project is researching, developing and evaluating decentralised algorithms, meta-information data structures and indexing techniques to enable large-scale data search
-
associated with the running of the project and the requirements of our funders. It is essential that you have a PhD in computer science, or equivalent professional qualifications and experience; ideally your
-
multiple long-term conditions navigate their social care needs. The position is full-time fixed-term until 01/04/2026. About you You will hold a PhD or equivalent professional qualification and experience
-
the laboratory of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics that has led to several therapeutics that are currently in